Similarly, both AKT and MAPK signaling result in activation of the AP1 transcription factor complex (FOS and JUN), and overexpression of these genes are associated with platinum resistance, while downregulation re-sensitizes tumor cells to platinum [115] (see also Supplementary Table S1). Here, JUN is linked to neoplasm.